TEL/AML1 fusion gene resulting from a cryptic t(12;21) is uncommon in adult patients with B-cell lineage ALL and CML lymphoblastic transformation

International Journal of Hematology

Volumn 66, Issue 2, 1997, Pages 213-218

  Hoshino, Koyu ^a   Asou, Norio ^a   Suzushima, Hitoshi ^a   Osato, Motomi ^a   Yamasaki, Hiroshi ^a   Okubo, Toshiya ^a   Nishimura, Shintaro ^a   Kiyokawa, Tetsuyuki ^b   Kawano, Fumio ^b   Takatsuki, Kiyoshi ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KUMAMOTO MEDICAL CENTER   (Japan)

Author keywords

Acute lymphoblastic leukemia; AML1; Chronic myeloid leukemia; t(12; 21); TEL

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; B LYMPHOCYTE; CHILDHOOD LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; FEMALE; HUMAN; LYMPHOCYTE TRANSFORMATION; MALE; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

EID: 0031214305     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0925-5710(97)00036-4     Document Type: Article

References (29)

1. Copelan E.A., McGuire E.A. The biology and treatment of acute lymphoblastic leukemia in adults. Blood. 85(5):1995;1151-1168.
2. Pui C.H., Crist W.M., Look A.T. Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood. 76:1990;1449-1463.
3. 1- patients. Br J Haematol. 36:1977;347-358.
4. Golub T.R., Barker G.F., Lovett M., Gilliland D.G. Fusion of PDGF receptor β to a novel ETS-like gene, TEL, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell. 77(2):1994;307-316.
5. Papadopoulos P., Ridge S.A., Boucher C.A., Stocking C., Wiedemann L.M. The novel activation of ABL by fusion to an ets-related gene TEL. Cancer Res. 55(1):1995;34-38.
6. Buijs A., Sherr S., Van B.S.et al. Translocation (12;22)(p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12 p13 to the MN1 gene on 22 q11. Oncogene. 10(8):1995;1511-1519.
7. Golub T.R., Barker G.F., Bohlander S.K.et al. Fusion of the TEL gene on 12 p13 to the AML1 gene on 21 q22 in acute lymphoblastic leukemia. Procs Nat Acad Sci USA. 92(11):1995;4917-4921.
8. Romana S.P., Mauchauffe M., Le C.M.et al. The t(12;21) of acute lymphoblastic leukemia results in a TEL-AML1 gene fusion. Blood. 85(12):1995;3662-3670.
9. Romana S., Poirel H., Leconiat M.et al. High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood. 86:1995;4263-4269.
10. Shurtleff S., Bujis A., Behm F.et al. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia. 9:1995;1985-1989.
11. McLean T.W., Ringold S., Neuberg D.et al. TEL/AML-1 dimerized and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. Blood. 88:1996;4252-4258.
12. 2-microglobulin gene. Primary structure and definition of the transcriptional unit. J Immunol. 139(9):1987;3132-3138.
13. Cross N.C., Melo J.V., Feng L., Goldman J.M. An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRNAs in hematological disorders. Leukemia. 8(1):1994;186-189.
14. Nadler L.M., Korsmeyer S.J., Anderson K.C.et al. B-cell origin of non-T cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre-B cell differentiation. J Clin Invest. 74(2):1984;332-340.
15. Kobayashi H., Rowley J.D. Identification of cytogenetically undetected 12 p13 translocations and associated deletions with fluorescence in situ hybridization. Genes Chromosomes Cancer. 12(1):1995;66-69.
16. Raynaud S., Mauvieux L., Cayuela J.M.et al. TEL/AML1 fusion is a rare event in adult acute lymphoblastic leukemia. Leukemia. 10(9):1996;1529-1530.
17. Shih L.Y., Chou T.B., Liang D.C.et al. Lack of TEL-AML1 fusion transcript resulting from cryptic t(12;21) in adult B lineage acute lymphoblastic leukemia in Taiwan. Leukemia. 10(9):1996;1456-1458.
18. Cayuela J.M., Baruchel A., Orange C.et al. TEL-AML1 fusion RNA as a new target to detect minimal resiatant disease in pediatric B-cell precursor acute lymphoblastic leukemia. Blood. 88:1996;302-308.
19. Vogelstein B., Fearon E.R., Hamilton S.R.et al. Genetic alterations during colorectal-tumor development. New Eng J Med. 319(9):1988;525-532.
20. Miyoshi H., Shimizu K., Kozu T., Maseki N., Kaneko Y., Ohki M. T(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc Nat Acad Sci USA. 88(23):1991;10431-10434.
21. Meyers S., Lenny N., Hiebert S.W. The t(8;21) fusion protein interferes with AML-1 B-dependent transcriptional activation. Mol Cell Biol. 15(4):1995;1974-1982.
22. Ogawa E., Inuzuka M., Maruyama M.et al. Molecular cloning and characterization of PEBP2β, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2α Virology. 194(1):1993;314-331.
23. Okuda T., Van D.J., Hiebert S.W., Grosveld G., Downing J.R. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell. 84(2):1996;321-330.
24. Shoemaker S.G., Hromas R., Kaushansky K. Transcriptional regulation of interleukin 3 gene expression in T-lymphocytes. Proc Nat Acad Sci USA. 87(24):1990;9650-9654.
25. Satake M., Inuzuka M., Shigesada K., Oikawa T., Ito Y. Differential expression of subspecies of polyomavirus and murine leukemia virus enhancer core binding protein, PEBP2, in various hematopoietic cells. Jpn J Cancer Res. 83(7):1992;714-722.
26. Takahashi A., Satake M., Yamaguchi I.Y.et al. Positive and negative regulation of granulocyte-macrophage colony-stimulating factor promoter activity by AML1-related transcription factor, PEBP2. Blood. 86(2):1995;607-616.
27. Nuchprayoon I., Meyers S., Scott L.M., Suzow J., Hiebert S., Friedman A.D. PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2β/CBFβ proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells. Mol Cell Biol. 14(8):1994;5558-5568.
28. Hiebert S.W., Sun W., Meyers S.et al. The t(12;21) translocation converts AML1-B from an activator to a repressor of trancription. Mol Cell Biol. 16(4):1996;1349-1355.
29. Maens M., Peeters P., Guo C., Aerssens J., Marynen P. Genomic organizaation of TEL: The human ETS-variant gene 6. Genome Res. 6(5):1996;404-413.